Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL283339 | 1.00 | CYP2D6 (0.44) | CYP2D6 | |
| SCHEMBL283340 | 1.00 | CYP2D6 (0.44) | CYP2D6 | |
| SCHEMBL7063746 | 0.86 | CYP2D6 (0.48) | CYP2D6 | |
| SCHEMBL11751768 | 0.80 | PKM (0.41) | — | |
| SCHEMBL22851451 | 0.80 | THRB (0.42) | — | |
| SCHEMBL11383973 | 0.80 | LMNA (0.36) | — | |
| SCHEMBL2245340 | 0.79 | CYP2D6 (0.44) | CYP2D6 | |
| SCHEMBL21587527 | 0.78 | ADRB3 (0.40) | — | |
| SCHEMBL4147093 | 0.78 | ALDH1A1 (0.35) | — | |
| SCHEMBL24192869 | 0.77 | CYP2D6 (0.43) | CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116203006-B | Multichannel fluorescent array sensor and construction and use method thereof | 中国药科大学 | 2025-04-25 | — | — | CN | claimed |
| CN-118580804-A | Water-based binder and application thereof in hard carbon negative electrode of sodium ion battery | 郑州大学 | 2024-09-03 | — | — | CN | claimed |
| CN-116203006-A | Multichannel fluorescent array sensor and construction and use method thereof | 中国药科大学 | 2023-06-02 | — | — | CN | claimed |
| WO-1998007653-A1 | CHIRAL HYDRIDE COMPLEXES | ZEELAND CHEMICALS, INC. (US) | 1998-02-26 | — | — | WO | claimed |
| US-20250304726-A1 | NITRIC OXIDE-RELEASING GLYCOSAMINOGLYCANS FOR WOUND HEALING | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250230406-A1 | CORNEAL ENDOTHELIAL CELL PREPARATION CONTAINING NO CULTURE-DERIVED COMPONENT, AND METHOD FOR PRODUCING SAME | THE DOSHISHA (JP) | 2025-07-17 | — | — | US | disclosed |
| WO-2025125099-A1 | HIGHLY SELECTIVE DIALYSIS MEMBRANES AND METHODS FOR PREPARING SAME | GAMBRO LUNDIA AB (SE) | 2025-06-19 | — | — | WO | disclosed |
| EP-4570364-A1 | HIGHLY SELECTIVE DIALYSIS MEMBRANES AND METHODS FOR PREPARING SAME | Gambro Lundia AB (SE) | 2025-06-18 | — | — | EP | disclosed |
| CN-116203006-B | Multichannel fluorescent array sensor and construction and use method thereof | 中国药科大学 | 2025-04-25 | — | — | CN | disclosed |
| EP-4501337-A1 | CORNEAL ENDOTHELIAL CELL PREPARATION CONTAINING NO CULTURE-DERIVED COMPONENT, AND METHOD FOR PRODUCING SAME | The Doshisha (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024179533-A1 | AQUEOUS BINDER AND USE THEREOF IN HARD CARBON NEGATIVE ELECTRODE OF SODIUM-ION BATTERY | 郑州大学 | 2024-09-06 | — | — | WO | disclosed |
| CN-118580804-A | Water-based binder and application thereof in hard carbon negative electrode of sodium ion battery | 郑州大学 | 2024-09-03 | — | — | CN | disclosed |
| US-20040186161-A1 | Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives | SUGEN, INC. | 2004-09-23 | — | — | US | disclosed |
| US-20030100555-A1 | Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives | SUGEN. INC. | 2003-05-29 | — | — | US | disclosed |
| US-6090950-A | Chiral hydride complexes | ZEELAND CHEMICALS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| WO-1998007653-A1 | CHIRAL HYDRIDE COMPLEXES | ZEELAND CHEMICALS, INC. (US) | 1998-02-26 | — | — | WO | disclosed |
| US-4521414-A | 1-TERT-BUTYLAMINO-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2 -PROPANOL AND SALTS THERFOF | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1985-06-04 | — | — | US | disclosed |
| EP-0105996-A1 | Ophthalmic compositions for treating elevated intraocular pressure | MERCK & CO. INC. (US) | 1984-04-25 | — | — | EP | disclosed |
| US-4097490-A | Pyroglutamic acid salts of t-butylamino-2,3-dihydroxypropane | MERCK & CO., INC. (US) | 1978-06-27 | — | — | US | disclosed |
| US-3998835-A | HYPERLIPOIDEMIA AND HYPERGLYCEMIA INHIBITORS, ANTIARRYHTHMIC AGENTS | SANDOZ LTD. (CH) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040186161-A1 | Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives | PLK2, CDK2, PDPK1 | CYP2D6 1461/4885 |
| US-20030100555-A1 | Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives | PLK2, CDK2, PDPK1 | CYP2D6 1461/4885 |
| US-20250304726-A1 | NITRIC OXIDE-RELEASING GLYCOSAMINOGLYCANS FOR WOUND HEALING | NOS2, NOS3, NOS1 | CYP2D6 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.